drugset / Trial / NCT00270036
A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety of epoetin alfa and to determine the effectiveness of epoetin alfa in reducing the need for blood transfusions after major orthopedic surgery. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.
Timeline
- Start
- 1991-04
- Primary completion
- —
- Completion
- 1991-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 100 iu/kg | Subcutaneous |
| Subject | epoetin alfa | Protein / enzyme biologic | 300 iu/kg | Subcutaneous |